compounded glp-1 ban ban: What providers need to know Compounded" GLP-1 drugs | Health

Jardiance is the brand name for empagliflozin, an oral SGLT2 inhibitor tablet used in adult cardiometabolic care

Exploring the emerging research on GLP-1 receptor agonists and Parkinson's disease: understand the science, clinical trials, potential benefits, risks, and why these diabetes medications are being investigated for neuroprotection.

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

I'm pleased to share that npj Metabolic Health and Disease is joining Communications Medicine on a new collection looking at the Therapeutic Landscape of GLP1 agonists.

NESS 2022 Abstracts: A Bariatric Surgery Derived Gut Metabolite is a Potent Single and Combination Oral Therapy for Type 2 Diabetes (T2D)